Parabon Nanolabs

Executive Summary

Parabon Nanolabs is a privately held biotechnology company specializing in the application of synthetic and human DNA for nano-pharmaceutical and forensic biomarker development. Founded in 2008 and based in Reston, Virginia, the company operates with a lean team of 1-10 employees, focusing on two core areas: chemically engineering synthetic DNA to design nanoscale pharmaceuticals, and mining human DNA to identify biomarkers with medical or forensic significance. Despite its small size, Parabon's dual approach positions it at the intersection of nanotechnology and genomics, targeting applications in drug delivery, disease diagnostics, and forensic analysis. The company's technology leverages the programmable properties of DNA to create precise molecular structures, potentially enabling targeted therapeutics with reduced side effects, as well as sensitive forensic tools for DNA phenotyping. However, the company's current stage and funding status remain undisclosed, and it has not yet commercialized any products, leading to uncertainty about its near-term progress.